U.S. Intel Assessment: Iran Signals No Quick Regime Change
A late-February U.S. intelligence assessment concluded that neither limited air strikes nor a prolonged war would lik...
Which Credit Cards Offer Cash Back Without Annual Fee
Learn about credit cards that offer cash back without an annual fee. Make an informed decision to boost your savings.
27,601 articles
GulfLink Backed by U.S.-Japan Funding for Deepwater Hub
A private Dallas developer secures a government-backed funding package to build a Gulf of Mexico deepwater oil termin...
Wells Fargo Hikes NVIDIA Target Ahead of Earnings Report
Wells Fargo lifts its NVIDIA price target to $315 ahead of the May earnings release, maintaining an Overweight rating...
Disabled Adult Child Benefit Sparks $1,800 Monthly Payout
A real-world case shows how the disabled adult child benefit can unlock substantial monthly income when a parent clai...
2-Year Treasury at 4.09%: Why Bitcoin Stays Grounded
The 2-year Treasury yield climbs to 4.09%, tightening liquidity and weighing on Bitcoin’s breakout attempt. Here’s wh...
Loeb Says Tech Is Most Attractive, Avoid Draconian Views
Hedge fund veteran Dan Loeb argues tech is the most attractive sector in the current rally, warning against draconian...
Catalyst Coming. Here's Smart: MP Materials Momentum
As a rare-earth supplier with the United States' only large-scale mine, MP Materials sits at a pivotal crossroads. If...
Fed’s Hawkish Stance Signals Dollar Shift, Markets Rally
The Fed’s hawkish stance signals a step-change in dollar sentiment as rates stay higher for longer, reshaping investm...
Micron Just Dropped 13%: Analyst Says Rally Stays Intact
Micron Technology shares tumbled about 13% ahead of its fiscal Q3 print, but one analyst argues the slide is a sentim...
Here's Shares Materials Declined: MP Materials Stock Insight
MP Materials faced a notable price drop in June, but the reasons run deeper than a single policy move. This article b...
FuelCell Energy Sinks 14% After Dilutive Share Sale
FuelCell Energy priced a $225 million stock offering at $21 per share, triggering a 14% slide and dragging peers Bloo...
Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status